Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy-Reference-Cited by-同舟云学术

Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy

Published:2021-03 Issue: Volume:22 Page:100324
ISSN:2405-6502
Container-title:eNeurologicalSci
language:en
Short-container-title:eNeurologicalSci

Author:

Bolz Saskia,Ramakrishnan Thivyah,Fleischer Michael,Livingstone Elisabeth,Stolte Benjamin,Thimm Andreas,Kizina Kathrin,Ugurel Selma,Kleinschnitz Christoph,Glas Martin,Zimmer Lisa,Hagenacker Tim

Publisher

Elsevier BV

Subject

Neurology

Reference39 articles.

1. The next immune-checkpoint inhibitors: PD-1/PD-L1 blockade in melanoma;Mahoney;Clin. Ther.,2015

2. Pooled analysis of Long-term survival data from phase II and phase III trials of Ipilimumab in Unresectable or metastatic melanoma;Schadendorf;J. Clin. Oncol.,2015

3. Structures of PD-1 with its ligands: sideways and dancing cheek to cheek;Freeman;Proc. Natl. Acad. Sci. U. S. A.,2008

4. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J. Exp. Med.,2000

5. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis;Rodig;Eur. J. Immunol.,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors-associated cranial nerves involvement: a systematic literature review on 136 patients;Journal of Neurology;2024-09-03

2. Pembrolizumab-induced myasthenia gravis: Two patients’ experiences;Gynecologic Oncology Reports;2024-08

3. Beyond T cell toxicity – Intrathecal chemokine CXCL13 indicating B cell involvement in immune‐related adverse events following checkpoint inhibition: A two‐case series and literature review;European Journal of Neurology;2024-03-31

4. Neurotoxizität;Onkologische Krankenpflege;2024

5. Neurological Adverse Effects of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T-Cell Therapy;World Journal of Oncology;2023-04